SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Fischer Medical Ventures Ltd

BSE: 524743 NSE: FISCHER ISIN: INE771F01041
  |   Sector:  Miscellaneous   |   Industry:  Trading

Snapshot

Q.1 Which industry/sub-sector does Fischer Medical Ventures Ltd belong to?
Fischer Medical Ventures Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.2 Is Fischer Medical Ventures Ltd a good quality company?
Fischer Medical Ventures Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Fischer Medical Ventures Ltd undervalued or overvalued?
Fischer Medical Ventures Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Fischer Medical Ventures Ltd a good buy now?
Fischer Medical Ventures Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd revenue growth is -54.7% for FY-2025 , which is below its 5 year CAGR of 96.1% , indicating slower growth.
Q.2 Gross Profit margin of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Gross profit margin which is the profit after deduction of direct costs, is 20.8% for FY-2025 , which is above its 5 year median of 0% , indicating increasing margins.
Q.3 Operating Profit Margin of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -42.86% for FY-2025 , which is below its 5 year median of -1.69% indicating decreasing margins.
Q.4 Net Profit Margin of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Net Profit Margin is 12.71% for FY-2025 , is above with its 5 year median of 3.49%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 20.8 -
Operating Profit Margin -42.86 -1.69
Net Profit Margin 12.71 3.49
Q.5 Return on Asset of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Return on Asset is 0.29%, which is in line with its 5 year historical median of 0.29%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Return on equity is 0.35% for FY-2025 , which is above its historical median of 0%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Return on capital employed is 0.53% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 13.5%, indicating value preservation.
Q.8 Cash conversion cycle of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Cash conversion cycle is 635 days, above its historical median of 0 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.02 0.25
ROE 0.35 -
ROCE 0.53 0.53
Cash Conversion Cycle 635 days -
Q.9 Debt to Equity ratio of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.03 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Debt to cash flow from operations is 0 , which is at a healthy level, indicating the business is able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Fischer Medical Ventures Ltd?
Promoters hold 61.80% of the Fischer Medical Ventures Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Fischer Medical Ventures Ltd vs industry peers?
Fischer Medical Ventures Ltd revenue CAGR is 96.10% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 5.2 13.3
Gross Profit 1 0.4
Operating Profit -2 0
Net Profit 1 0.3
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.02 0.5
ROE 0.35 2.03
ROCE 0.53 3.6
Cash Conversion Cycle (days) 635.48 41

Valuation & price assessment

Q.1 Stock return of Fischer Medical Ventures Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 69.1% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 69.1% 73.6% 68.5% -50.9%
Q.3 Valuation ratios of Fischer Medical Ventures Ltd vs historical?
The current P/E is similar that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings - 0.00 21.75
Price to Book 8.18 -5.41 1.55
Price to Sales 142.12 0.00 1.87
EV to EBITDA 1108.03 -12.04 13.67

Check more companies

1. Aditya Infotech
2. Aegis Logistics
3. Redington
4. RRP Semiconductor
5. Honasa Consumer
6. Cello World
7. Lloyds Enterprises
8. MMTC
9. Jeena Sikho Life
10. SG Mart
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×